Effects of COX-1 and COX-2 Inhibitors on Ovarian Cancer in Mice
Author Information
Author(s): Li Wei, Wang Jie, Jiang Hong-Ru, Xu Xiao-Li, Zhang Jun, Mei-Lin Zhai, Ling-Yun
Primary Institution: Nanjing Medical University of Hangzhou Hospital
Hypothesis
A combination of COX-1 and COX-2 selective inhibitors should reduce the growth of tumors more effectively than either agent alone.
Conclusion
The combination of COX-1 and COX-2 selective inhibitors significantly suppressed tumor growth in ovarian cancer models.
Supporting Evidence
- The combination of SC-560 and celecoxib showed a 35.54% reduction in tumor growth compared to the control group.
- Cell proliferation was significantly lower in the combination group compared to the control group.
- The apoptosis index was significantly higher in the combination group than in the control group.
Takeaway
Using two special medicines together can help stop cancer from growing better than using just one medicine.
Methodology
Mice with human ovarian cancer cells were treated with COX-1 and COX-2 inhibitors, and tumor growth was measured over three weeks.
Limitations
The study was conducted in a mouse model, which may not fully replicate human ovarian cancer.
Participant Demographics
Nude female mice, 7-8 weeks old.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website